About: Antimicrobial resistance

I want to empower patients, says Green group’s health expert

“What kind of europe do we want? A Europe that puts patients’ needs at the forefront, or that prioritises the interests of big pharma?” says Greens health expert Tilly Metz

Belgian presidency calls for coordinated action against antimicrobial resistance

How do you envisage the creation of a product which you ideally don’t want to use? That was the focal point of the Belgian presidency’s high-level meeting on how the EU should coordinate its response to antibiotic resistance (AMR).

EU falling behind 2030 antimicrobial consumption targets, health agency finds

The EU is falling short of reaching the antimicrobial consumption targets for 2030 with some member states even backtracking from 2019 numbers, a new report by the European Centre for Disease Prevention and Control has found.

EU to test disputed incentive scheme to develop novel antibiotics

The revamp of the bloc's regulatory framework for pharmaceuticals, presented by the European Commission on Wednesday (26 April), features a new and somewhat controversial system of incentives to promote the development of new antimicrobials.

LEAK: Commission enlists help of stakeholders to reshape EU pharma sector

The European Commission will call for "cooperation between different stakeholders to bring about positive change" in the pharmaceutical sector, according to a leaked communication accompanying the revision of the EU's drug framework.

Commission to seek patient-centred, industry-friendly pharma rules reform

With only a few weeks before unveiling the EU's revamped framework for pharmaceuticals, Health Commissioner Stella Kyriakides described the main drivers of the much-awaited reform, stressing the importance of finding the balance between patients' and industry's interests.

EU countries see success in slashing veterinary antibiotics sales

Sales of antibiotics used for animal use have almost halved between 2011-2021, according to a new report issued by the European Medicines Agency (EMA), putting the EU on track to attain its ambitions, but with a warning that the sector should not become complacent.

35,000 annual deaths in Europe due to superbugs, says EU agency

As deaths due to antimicrobial resistance (AMR) rise, public health actions aimed at tackling AMR are insufficient, according to a report by the European Centre for Disease Prevention and Control (ECDC) published Thursday (17 November).

Cut animal transport times to reduce rise of superbugs, says EU agency

Animal transportation times should be cut to reduce the risk of spreading antimicrobial resistance, according to a new scientific opinion from the European Food Safety Authority (EFSA).

List of antimicrobials still disputed despite endorsement by member states

The EU member states have now formally given their support to the list of antimicrobials reserved for human use proposed by the Commission. Despite this, the criticism has not died down.

WOAH chief: Protecting environment key to ensuring human, animal health

The COVID-19 crisis has underscored that there is no way to ensure human and animal health without wider consideration of environmental health, Monique Eloit, Director General of the World Organisation for Animal Health, told EURACTIV in an interview.

One Health approach: Time for implementation

Download PDF  

In the wake of the COVID pandemic, and with the race against antibiotic resistance becoming ever more pressing, it is more important than ever to make the 'One Health' approach a reality.

Commission defends ‘humans only’ antimicrobials list saved by MEPs

The European Commission’s list of antimicrobials to be reserved for human use only is based on sound scientific evidence, an EU official stressed after EU lawmakers reiterated their objection to the act implementing it.

Commission: Disputed antimicrobial should be restricted, but not reserved for human use

European lawmakers are still not impressed by the EU executive's strong defence of its stance on the disputed antimicrobial colistin, as disagreements surrounding the list of antimicrobials to be reserved for human use continue.

EU not on track to reduce livestock antibiotics, say campaigners

EU and national policies are not ambitious enough to reach the bloc's goal of halving antibiotic use in livestock farming by 2030, according to campaigners, who warn that without sufficient action, humans will also be at risk from antimicrobial resistance.

Commission confirms support for EMA’s advice on antimicrobials for humans only

Health commissioner Stella Kyriakides reaffirmed support for the European Medicines Agency (EMA)'s set of recommendations for antimicrobials to be reserved for humans only despite criticism over the non-inclusion of colistin, an antibiotic used in veterinary medicine.

Better tools are need to end tuberculosis and anti-microbial resistance

We need better tools to end TB and AMR, and the EU can and must lead these efforts, writes Nicolae Ștefănuță.

MEPs slam new recommendations on antimicrobials reserved for human use

European lawmakers did not hold back in their criticism of the new European Medicines Agency (EMA) recommendations for antimicrobials to be reserved for human use at a committee meeting on Tuesday (15 March).